Exelixis Inc (EXEL)

01:25 AM

Exelixis at 45th Annual William Blair Conference: Oncology Ambitions - Investing.com Australia

01:25 AM

12:20 PM

Transcript : Exelixis, Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10 - marketscreener.com

12:20 PM

Jun 02, 2025

Here's Why Exelixis (EXEL) is a Strong Growth Stock - Yahoo Finance

Jun 02, 2025

Jun 02, 2025

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Growth in the Biotech Space with Robust Revenue Momentum - DirectorsTalk Interviews

Jun 02, 2025

May 30, 2025

2 Top Stocks to Buy With Less Than $100 - AOL.com

May 30, 2025

May 28, 2025

Why Exelixis (EXEL) is a Top Value Stock for the Long-Term - Yahoo Finance

May 28, 2025

May 27, 2025

Transcript : Exelixis, Inc. Presents at TD Cowen's 6th Annual Oncology Innovation Summit, May-27-2025 02 - marketscreener.com

May 27, 2025

May 27, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Decreases Stake in Exelixis, Inc. (NASDAQ:EXEL) - Defense World

May 27, 2025

May 25, 2025

EXEL Reports Superior Efficacy Data From Kidney Cancer Study Cohort - MSN

May 25, 2025

May 25, 2025

Exelixis’s SWOT analysis: stock poised for growth amid oncology pipeline progress By Investing.com - Investing.com South Africa

May 25, 2025

May 25, 2025

Exelixis’s SWOT analysis: stock poised for growth amid oncology pipeline progress - Investing.com Australia

May 25, 2025

May 25, 2025

Deutsche Bank AG Has $1.54 Million Stake in Exelixis, Inc. (NASDAQ:EXEL) - Defense World

May 25, 2025

May 24, 2025

Insider Sell: Tomas Heyman Sells Shares of Exelixis Inc (EXEL) - GuruFocus

May 24, 2025

May 23, 2025

3 Reasons Why Growth Investors Shouldn't Overlook Exelixis (EXEL) - Yahoo Finance

May 23, 2025

May 23, 2025

Earnings Estimates Moving Higher for Exelixis (EXEL): Time to Buy? - Yahoo Finance

May 23, 2025

May 23, 2025

Exelixis (EXEL) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

May 23, 2025

May 23, 2025

Solid Earnings Reflect Exelixis' (NASDAQ:EXEL) Strength As A Business - Yahoo Finance

May 23, 2025

May 23, 2025

Product Performance, Big Money Lift Exelixis - Yahoo Finance

May 23, 2025

May 23, 2025

Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ASCO 2025 - BioSpace

May 23, 2025

May 23, 2025

Exelixis reports promising kidney cancer trial results - Investing.com Australia

May 23, 2025

May 23, 2025

Exelixis EVP Haley Patrick J. sells $1.5 million in stock By Investing.com - Investing.com Nigeria

May 23, 2025

May 22, 2025

Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-0 - GuruFocus

May 22, 2025

May 22, 2025

Exelixis EVP Haley Patrick J. sells $1.5 million in stock - Investing.com

May 22, 2025

May 22, 2025

Exelixis Executives Engage in Significant Stock Transactions - TradingView

May 22, 2025

May 22, 2025

Exelixis reports promising kidney cancer trial results By Investing.com - Investing.com India

May 22, 2025

May 22, 2025

Exelixis (EXEL) Reports Promising Results from STELLAR-002 Renal Cancer Trial | EXEL Stock News - GuruFocus

May 22, 2025

May 22, 2025

Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ASCO 2025 | EXEL Stock N - GuruFocus

May 22, 2025

May 22, 2025

Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May and June | EXEL Stock News - GuruFocus

May 22, 2025

May 22, 2025

Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May and June - New Castle News

May 22, 2025

May 22, 2025

Long Term Trading Analysis for (EXEL) - news.stocktradersdaily.com

May 22, 2025

May 21, 2025

Exelixis (NasdaqGS:EXEL) Reports Robust Q1 2025 Earnings and Revenue Growth - Yahoo Finance

May 21, 2025

May 20, 2025

Exelixis, Inc.: A Strategic Buy on Positive Momentum - marketscreener.com

May 20, 2025

May 20, 2025

Transcript : Exelixis, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-20-2025 10 - marketscreener.com

May 20, 2025

May 19, 2025

Exelixis (EXEL) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

May 19, 2025

May 19, 2025

Unlocking Exelixis (EXEL) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance

May 19, 2025

May 18, 2025

CoreWeave, Super Micro Computer And Coinbase Are Among Top 11 Large-Cap Gainers Last Week (May 12-May 16): Are The Others In Your Portfolio? - Benzinga

May 18, 2025

May 17, 2025

Citigroup Boosts Exelixis (NASDAQ:EXEL) Price Target to $56.00 - Defense World

May 17, 2025

May 17, 2025

Exelixis raises 2025 revenue guidance by $100M amid strong CABOMETYX market share gains and new NET approval - MSN

May 17, 2025

May 16, 2025

Exelixis director George Poste sells $948,957 in stock - Investing.com Australia

May 16, 2025

May 16, 2025

Exelixis director George Poste sells $948,957 in stock By Investing.com - Investing.com UK

May 16, 2025

May 16, 2025

Exelixis Stock Price, Quotes and Forecasts - Benzinga

May 16, 2025

May 16, 2025

Exelixis (NASDAQ:EXEL) Stock Price Up 5.7% After Analyst Upgrade - Defense World

May 16, 2025

May 15, 2025

Exelixis Q1 2025 Earnings Call Highlights Growth - TipRanks

May 15, 2025

May 15, 2025

Guggenheim Raises Price Target for Exelixis (EXEL) Amid Strong R - GuruFocus

May 15, 2025

May 15, 2025

EXEL Q1 Earnings Beat, 2025 Sales View Up as Cabometyx Drives Top Line - MSN

May 15, 2025

May 15, 2025

Demystifying Exelixis: Insights From 8 Analyst Reviews - Benzinga

May 15, 2025

May 15, 2025

Exelixis (EXEL) Target Price Raised by Citigroup Analyst | EXEL Stock News - GuruFocus

May 15, 2025